Photo from archive.org
Micro-injections of METH (2–8 μg) in the NAc core and NAc shell significantly enhanced locomotor activity in a dose dependent manner (Fig. 4a, b; F3, 32 = 6.444, P =… Click to show full abstract
Micro-injections of METH (2–8 μg) in the NAc core and NAc shell significantly enhanced locomotor activity in a dose dependent manner (Fig. 4a, b; F3, 32 = 6.444, P = 0.002, and n = 9 in each group and F3, 36 = 6.66, P = 0.001, and n = 10 in each group, respectively, as assessed by one-way ANOVA) but not for mPFC (F3, 20 = 1.858, P > 0.05, and n = 6 in each group and F3, 28 = 0.715, P > 0.05, and n = 8 in each group, respectively, as assessed by one-way ANOVA). Also, Figs. 2e, f and 3e, f are incorrect. The corrected 2 and 3 figures are shown on the following page:
Journal Title: Metabolic Brain Disease
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!